Understanding Vitamin K2: MK-4 vs. MK-7
Vitamin K is a fat-soluble vitamin essential for blood coagulation, bone metabolism, and cardiovascular health. While vitamin K1 (phylloquinone) is found primarily in leafy greens, vitamin K2 (menaquinones) is a family of compounds represented by MK-n, where 'n' denotes the number of isoprenoid side chains. The two most commonly discussed forms are menaquinone-4 (MK-4) and menaquinone-7 (MK-7).
While the body can convert vitamin K1 and MK-7 into MK-4, the properties of the supplemental forms differ significantly, leading to important distinctions in their use and efficacy. The primary areas of difference include their source, bioavailability, half-life, and required dosage to achieve therapeutic effects.
The Fundamental Differences: Bioavailability and Half-Life
One of the most critical factors distinguishing MK-4 and MK-7 is their half-life in the bloodstream. A vitamin's half-life determines how long it remains active and available for the body's tissues to use.
-
MK-4's Short Half-Life: MK-4 has a very short half-life, lasting only a few hours after consumption. This means it is rapidly cleared from the circulation. Because of this, maintaining consistent therapeutic levels requires frequent, large doses. Supplemental MK-4 is quickly absorbed but also quickly utilized or cleared.
-
MK-7's Long Half-Life: In contrast, MK-7 boasts a significantly longer half-life, remaining in the bloodstream for several days (up to 72 hours). This extended availability allows for better accumulation in the blood and more consistent activation of vitamin K-dependent proteins in various tissues, especially extrahepatic ones like bone and cartilage.
Bioavailability Differences
Bioavailability refers to the proportion of a nutrient that is absorbed and becomes available for the body's physiological functions. This is where the half-life difference directly translates to different practical outcomes:
-
MK-4's Bioavailability: At typical nutritional supplement doses (microgram range), MK-4 is poorly absorbed and often undetectable in the serum. Clinical studies have shown that high doses (milligram range) are required to produce a detectable increase in serum levels and achieve therapeutic effects, particularly for bone health.
-
MK-7's Bioavailability: MK-7 is well-absorbed and demonstrates high bioavailability, even at smaller, microgram doses. Its prolonged presence in the circulation ensures better absorption and utilization by the body over time compared to MK-4.
Natural Sources, Synthesis, and Dosages
The source and manufacturing process also differ for the two menaquinones.
MK-4
- Sources: Naturally, MK-4 is found in animal products like eggs, meat, and high-fat dairy, such as butter and cheese. However, the human body can also convert vitamin K1 and other menaquinones into MK-4 in various tissues.
- Synthetic Production: Supplemental MK-4 is typically produced synthetically.
- Dosage: Effective therapeutic doses for MK-4 are much higher than MK-7, often requiring 45 mg (45,000 mcg) daily, typically split into three smaller doses, to significantly impact bone density.
MK-7
- Sources: MK-7 is produced by bacteria and is found in high concentrations in fermented foods. The Japanese fermented soybean dish natto is an exceptionally rich dietary source of MK-7.
- Natural Production: Many high-quality MK-7 supplements are made by bacterial fermentation using Bacillus subtilis.
- Dosage: Due to its superior bioavailability and long half-life, MK-7 is effective at much lower dosages. Studies suggest a daily intake of 100-180 mcg is sufficient for activating key proteins related to bone and cardiovascular health.
Comparison Table: MK-4 vs. MK-7
| Feature | Menaquinone-4 (MK-4) | Menaquinone-7 (MK-7) |
|---|---|---|
| Natural Source | Animal products (eggs, meat, liver, dairy fat) | Fermented foods, especially natto |
| Synthetic Form | Commonly sold synthetically | Often derived from natural fermentation |
| Half-Life | Very short (hours) | Very long (days, ~72 hours) |
| Bioavailability | Poor at low nutritional doses; high doses needed for serum detection | High at low nutritional doses; well-absorbed and accumulates in serum |
| Dosage | Requires high doses (45 mg/day) and multiple daily intakes for therapeutic effect | Effective at low doses (100-180 mcg/day), usually taken once daily |
| Target Tissues | Widely distributed in tissues like arteries, pancreas, brain | Especially effective for extrahepatic tissues like bones and blood vessels due to long circulation |
Health Benefits and Efficacy
Both MK-4 and MK-7 contribute to critical health processes by activating vitamin K-dependent proteins (VKDPs) that regulate calcium metabolism. These include:
-
Bone Health: Activating osteocalcin, a protein that directs calcium to bone tissue to improve mineralization and strength. MK-4 has a longer history of use in high doses for osteoporosis treatment, with strong evidence for increasing bone mineral density and reducing fractures. MK-7, due to its consistent activation of osteocalcin, also provides robust support for maintaining bone health and quality over time, and is often preferred for long-term maintenance.
-
Cardiovascular Health: Activating Matrix Gla Protein (MGP), which helps prevent calcium from depositing in soft tissues like arteries. MK-7's prolonged presence in the blood makes it particularly effective for consistently targeting MGP and reducing arterial calcification.
Choosing Between MK-4, MK-7, or Both
When selecting a vitamin K2 supplement, consider your primary health goals and lifestyle.
-
Consider MK-7 if: You prioritize convenience with a once-daily, lower-dose supplement. Its excellent bioavailability and long half-life are ideal for consistent, long-term support for bone and cardiovascular health, and it serves as an efficient precursor for the body's endogenous MK-4 production.
-
Consider MK-4 if: Your primary goal is improving bone density and you are willing to follow a high-dose, multiple-times-per-day regimen, especially under medical supervision. The research backing high-dose MK-4 for osteoporosis is well-established. It may also be beneficial for those who do not tolerate MK-7 well.
-
Consider a combination if: You want to leverage the unique benefits of both forms. Some experts recommend a combined supplement to ensure high, consistent blood levels from MK-7 and targeted tissue benefits from MK-4. A typical combined product contains both forms in dosages reflecting their individual effective ranges.
Regardless of your choice, it is vital to ensure you select a high-quality supplement. Many products on the market do not meet label claims due to issues with isomer purity and stability. Look for supplements specifying "all-trans" isomers and using proper encapsulation technology to protect the vitamin's potency, especially if combined with minerals like calcium. Consult a healthcare provider before starting any new supplement regimen, particularly if you are on blood-thinning medication.
Conclusion
While MK-4 and MK-7 are both vital forms of vitamin K2, their differences in source, bioavailability, and half-life lead to different applications and dosing strategies. MK-7 is highly favored for its superior bioavailability and convenience, providing consistent benefits for bone and heart health with a simple, once-daily dose. In contrast, MK-4 is the biologically active form found in tissues and has a solid evidence base for bone density improvement, though it requires a much higher, more demanding dosing schedule. Ultimately, the best choice depends on your specific health objectives and lifestyle, with combination supplements offering a way to receive the complementary benefits of both potent menaquinones.
For more detailed information on the metabolic distinctions between Vitamin K1 and K2, refer to research published in the International Journal of Molecular Sciences on the topic.
